Teva news
Information on the detection of impurity in an active pharmaceutical substance used in the manufacture of certain drugs containing valsartan
(the communication applies to valsartan drugs produced by Teva/Actavis Company)
Charitable Event of ODR-Eurasia for Patients with Parkinson's Disease
Every year on April 11, the whole world celebrates World Day against Parkinson's disease (on the birthday of the English scientist J. Parkinson, the first researcher of the disease).
Teva Kazakhstan participated as a benefactor in the Action of "Scandinavian Walking Wins Parkinson's Disease - Marathon of Two Capitals" which was organized by the RPO "ODR-Eurasia" and was held on 11 of April of this year in Almaty and Astana
We have launched the multiple sclerosis information portal.
We are pleased to announce that the Multiple Sclerosis Information Portal «For Yourself. For the freedom ", created with the support of Teva Kazakhstan, starts its work since 20 of March
The first medical forum of Teva "Cardio Sphere"
The first medical forum Teva "Cardio Sphere" was hosted in Moscow on October 6-7 of 2017
Teva took part in the conference "Kaishibayev Readings"
Teva took part in the conference «Kaishibayev Readings» as one of the main sponsors which was on October 6-7 of 2017 and held a satellite symposium in the framework of the conference.
«Antibiotic therapy: yesterday, today and tomorrow» themed conferences were held in Almaty, Astana and Karaganda.
On the eve of the autumn-winter season of upper and lower respiratory tract infections "Antibiotic therapy: yesterday, today and tomorrow» themed conferences were held in Almaty, Astana and Karaganda on October 2-4, 2017
Master-class for doctors on "Tactical solutions of antihypertensive therapy of comorbid patients"
Master-class on the theme "Tactical solutions of antihypertensive therapy of comorbid patients" was held for general practitioners, therapists and cardiologists in Almaty on September 23 of 2017
Comments on the Teva financial report for Q2 of 2017
On August 3, Teva published its financial report for the second quarter of 2017, in which, particularly, it was said that the company was cutting back operations in 45 countries.
Teva Webinars portal
We improve the quality and extend interaction with healthcare professionals, due to this we launch a webinar portal.
On March 4, the very first and unique online webinar was held within the "Glatiramer acetate 40 mg" symposium: Today principles and optimization of therapy for patients with remittent multiple sclerosis.
TEVA completes the acquisition of ACTAVIS GENERICS
This transaction strengthens Teva's strategy, facilitates an accelerated transition to a new business model and opens up new opportunities for the company in the production of generics and specialty. The company provides medicinal products to 250 million people around the world every day.